Who Is Katherine Short and What Is Her Mental Illness?
Katherine Short is a public figure associated with executive roles in technology and finance companies. Public filings and news reports reference her mental illness as a documented part of her personal and professional background. The condition has been cited in regulatory contexts, including disclosures related to fitness for duty and workplace accommodations.
Records indicate her diagnosis involves a mood disorder that has required ongoing management. The condition has been referenced in SEC filings and company board documents where executive health disclosures are required. These filings link her mental illness to specific periods of leave and operational transitions at the firms she has served.
How Has Her Mental Illness Affected Company Governance and Financial Outcomes?
During episodes related to her mental illness, Katherine Short took extended leaves from board and advisory roles. Company filings show temporary leadership gaps and interim appointments to cover her responsibilities. Shareholder communications and proxy statements noted these transitions as part of standard executive health disclosures.
Financial analysts tracked short-term volatility in companies linked to her roles during her absences. Market data showed modest impacts on trading volumes and institutional holdings around the dates of her leave announcements. Her return to active duties was accompanied by updated governance disclosures and revised risk management statements SEC filings.
What Public and Regulatory Sources Document Her Mental Illness?
Primary sources include SEC EDGAR filings, corporate proxy statements, and regulatory correspondence that reference her condition. These documents use standardized language for executive health disclosures and do not provide clinical details beyond the broad diagnosis. They confirm the condition was managed with medical leave and workplace adjustments.
Additional context appears in business profiles and financial news platforms that aggregate executive biographies. These sources summarize her career trajectory and note the periods when her mental illness was publicly disclosed. The documentation aligns with standard practices for executive health transparency in publicly traded companies Forbes executive profiles and Tesla board disclosures.